Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GFL Environmental Inc. Subordinate voting shares no par value (GFL) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance

GFL Environmental Inc. Subordinate voting shares no par valueTrade
Oruka Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

GFL Environmental Inc. Subordinate voting shares no par value vs Oruka Therapeutics Inc. Common Stock — how do they compare? GFL Environmental Inc. Subordinate voting shares no par value trades at $42.95 (market cap $18.64B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: GFL Environmental Inc. Subordinate voting shares no par value is far larger — about 3.6× Oruka Therapeutics Inc. Common Stock's market cap, and GFL Environmental Inc. Subordinate voting shares no par value pays a 0.16% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold GFL Environmental Inc. Subordinate voting shares no par value for 6 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.

GFLORKA
Market Cap
$18.64B$5.18B
Volume
2,514,524490,798
Sector
IndustrialsHealth
52-Week High
$46.51$113.08
52-Week Low
$33.54$26.19
Typical Hold Time
6 Days0 Days
Enterprise Value
$25.61B$4.31B
Dividend Yield
0.16%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GFL Environmental Inc. Subordinate voting shares no par value

GFL trades at $42.75, up 0.87% today, with a bullish technical signal from moving averages. Recent Q2 2026 earnings missed estimates, but the company raised full-year 2026 guidance. Revenue is projected to grow to $7.0B in 2026, though net income is expected to turn negative. The company recently acquired SECURE Waste Infrastructure and announced a quarterly dividend, signaling financial activity.

Outlook is mixed: strong analyst buy consensus (77.8%) and positive news flow support upside, but negative profit margins and high valuation ratios pose risks. The stock's performance hinges on execution of growth initiatives and margin improvement in a competitive industrial sector.

Oruka Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GFL

No sentiment data available yet.

ORKA
100% Buy0% Sell
Avg holding period · 0 Days

About GFL Environmental Inc. Subordinate voting shares no par value

GFL Environmental provides environmental services across Canada and the United States. Its operations include solid waste management and other waste and environmental solutions.

Read more on GFL →

About Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.

Read more on ORKA →